Wednesday, 17 April 2013

Singing from the same hymn sheet


Last June we made a bid to become Royal Mail’s charity partner, and won. Royal Mail was an obvious choice for us – a national company that is part of everyone’s daily life and which employs a lot of men. You couldn’t design a better charity partner for Prostate Cancer UK if you tried.
The Royal Mail Group has already raised £800,000 to help us beat prostate cancer, which is a phenomenal amount of money. From growing Mos for Movember and crazy cycling challenges, to supporting our awareness campaign by obliterating walnuts, the Royal Mail has taken our cause to heart and jumped straight into the thick of raising money and awareness.
The latest in the series of first-class (sorry) fundraising initiatives by Royal Mail is this stirring rendition of the famous hymn ‘Abide with Me’. X-Factor winner Joe McElderry, and the Royal Mail Choir, have teamed up to record the single to raise funds and awareness for Prostate Cancer UK. I think you’ll agree it’s pretty special.


You can download this single now from Amazon and iTunes for 99p. For every download Royal Mail is donating an extra £1 to the charity, so I’d urge you to buy it.
Huge thanks must go to the men and women in the Royal Mail Choir who managed to fit in time around their normal jobs to practice and put this track together. Thanks also to Joe McElderry for taking time out from his busy schedule to record and promote Abide with Me to help men across the UK get a better deal.
Our partnership with Royal Mail is already having an impact in local communities. The money they have raised has funded the creation of four specialist prostate cancer nurse roles based around the UK. These nurses provide much needed local support to men affected by prostate cancer, and the money raised by Abide with Me will help us fund more nurses to reach more men in their own communities. So next time you open your door to your local postman or postwoman, give them a pat on the back and a thank you from all of us at Prostate Cancer UK.

No comments:

Post a Comment